MiroBio is Harnessing the natural control mechanisms of the immune system.
MiroBio has raised $97.0M in total funding. The most recent round was Series B. The last funding was announced in June 2022.
MiroBio's investors include Samsara BioCapital, Oxford Science Enterprises, OrbiMed, SR One, Medicxi.
MiroBio is headquartered in Oxford, United Kingdom.
MiroBio is Harnessing the natural control mechanisms of the immune system.
MiroBio is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MiroBio — Funding & Investors." VCBacked, June 29, 2022, https://www.vcbacked.co/company/mirobio. Accessed November 14, 2026.
VCBacked. (2022). MiroBio — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/mirobio
{{cite web |title=MiroBio — Funding & Investors |url=https://www.vcbacked.co/company/mirobio |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at MiroBio? Request a listing update